These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29140646)

  • 1. Early Developments in the Regulation of Biologics.
    Coleman TS
    Food Drug Law J; 2016; 71(4):544-607. PubMed ID: 29140646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first pharmacoepidemiologic investigations: national drug safety policy in the United States, 1901-1902.
    Lilienfeld DE
    Perspect Biol Med; 2008; 51(2):188-98. PubMed ID: 18453724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The history of regulatory system for plasma fractionation products in the United States].
    Fukuzawa M; Tsutani K
    Yakushigaku Zasshi; 2014; 49(2):205-13. PubMed ID: 25799842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early history of regulatory requirements for poultry biologics in the United States.
    Espeseth DA; Lasher H
    Avian Dis; 2010 Dec; 54(4):1136-43. PubMed ID: 21313831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Governmental oversight of prescribing medications: history of the US Food and Drug Administration and prescriptive authority.
    Plank LS
    J Midwifery Womens Health; 2011; 56(3):198-204. PubMed ID: 21535368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forbidden and Permitted Statements about Medications--Loosening the Rules.
    Avorn J; Sarpatwari A; Kesselheim AS
    N Engl J Med; 2015 Sep; 373(10):967-73. PubMed ID: 26332553
    [No Abstract]   [Full Text] [Related]  

  • 7. Rethinking 'flexibilities' in the international drug control system-Potential, precedents and models for reforms.
    Collins J
    Int J Drug Policy; 2018 Oct; 60():107-114. PubMed ID: 28129946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act.
    Cooper DE
    Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of follow-on biologics.
    Frank RG
    N Engl J Med; 2007 Aug; 357(9):841-3. PubMed ID: 17761588
    [No Abstract]   [Full Text] [Related]  

  • 10. Administrative detention of drugs intended for human or animal use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2014 May; 79(103):30716-21. PubMed ID: 24873018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D; Tobbell DA
    Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tobacco, public health, and the FDA.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2009 Jul; 361(4):402-3. PubMed ID: 19546344
    [No Abstract]   [Full Text] [Related]  

  • 13. Preclinical assessment of abuse liability of biologics: In defense of current regulatory control policies.
    Gauvin DV; Zimmermann ZJ; Baird TJ
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):43-54. PubMed ID: 26107292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. '1996' starting the modern era of biologics regulation: FDA's elimination of establishment licensure and other changes.
    Gamerman GE; Mackler BF; Landa MM
    Biotechnol Appl Biochem; 1997 Jun; 25(3):189-95. PubMed ID: 9198272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological products regulated under Section 351 of the Public Health Services Act; implementation of biologics license; elimination of establishment license and product license--FDA. Proposed rule.
    Fed Regist; 1998 Jul; 63(147):40858-71. PubMed ID: 10181717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The trouble with drink and drugs: why prohibition and criminalization matter.
    Levine HG; Reinarman C
    Addiction; 2010 May; 105(5):806-7. PubMed ID: 20402973
    [No Abstract]   [Full Text] [Related]  

  • 17. The Atlanta Falcon and Tono-Bungay: dietary supplements as subprime drugs.
    Weissmann G
    FASEB J; 2009 May; 23(5):1279-82. PubMed ID: 19406845
    [No Abstract]   [Full Text] [Related]  

  • 18. Framing processes in public commentary on US federal tobacco control regulation.
    Roth AL; Dunsby J; Bero LA
    Soc Stud Sci; 2003 Feb; 33(1):7-44. PubMed ID: 12918520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological products regulated under Section 351 of the Public Health Service Act; implementation of biologics license; elimination of establishment license and product license; public workshop--FDA. Proposed rule; notice of workshop.
    Fed Regist; 1998 Aug; 63(154):42773-4. PubMed ID: 10182565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Not as easy as it may appear: using radio frequency identification technology to fulfill the Prescription Drug Marketing Act's elusive pedigree requirement.
    Asamoah AK
    Food Drug Law J; 2006; 61(2):385-418. PubMed ID: 16903035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.